JR

Jitendrapratap Rambahadur Singh

Active Director Whole-Time Director DIN 09796568
DIN 09796568 First appointment Nov 2022 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Total affiliations 2 Since Nov 2022
Shareholding value •••• Premium profile

About Jitendrapratap Rambahadur Singh

Data last updated:

Jitendrapratap Rambahadur Singh is a Whole-Time Director at Brooks Laboratories Limited (since 2022) and Whole-Time Director at Abridge Speciality Limited (since 2026). The companies operate in Pharma. The largest current company by reported revenue is Brooks Laboratories Limited at ₹83.44 Cr (FY 2025).

DIN 09796568
Primary Designation Whole-Time Director
Industry Pharma
First Appointment 23 Nov 2022
Oldest Company Age 24 yrs
Largest company Brooks Laboratories Limited · ₹83.44 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Brooks Laboratories Limited L24232HP2002PLC000267
Whole-Time Director23 Nov 20222002₹83.44 Cr (FY 2025)Active
Abridge Speciality Limited U21001HP2026PLC012813
Whole-Time Director02 Jul 20262026Active

Board colleagues of Jitendrapratap Rambahadur Singh

NameDINCompanyDesignation
Bhushan Singh Rana10289384Brooks Laboratories Limited , Abridge Speciality LimitedWhole-Time Director
Durga Shankar Maity03136361Brooks Laboratories Limited , Abridge Speciality LimitedWhole-Time Director
Krutika Mohan RaneBrooks Laboratories LimitedCompany Secretary
Lalit Mahajan03270819Brooks Laboratories LimitedDirector
Manav Mahajan10721554Brooks Laboratories LimitedDirector
Prashant RathiBrooks Laboratories Limited , Abridge Speciality LimitedCfo
Usha Singh10706734Brooks Laboratories LimitedDirector
Atul Ranchal01998361Abridge Speciality LimitedIndividual Subscriber
Davinder Kumari06651225Abridge Speciality LimitedIndividual Subscriber
Rajni Ranchal06651133Abridge Speciality LimitedIndividual Subscriber
Savvy Ranchal09672351Abridge Speciality LimitedIndividual Subscriber
Selina RanchalAbridge Speciality LimitedIndividual Subscriber
Sheetal Arvind Singh09741912Abridge Speciality LimitedIndividual Subscriber
U21001hp2026plc012813 U21001hp2026plc012813Abridge Speciality LimitedCompany/Llp

Directorship timeline

Open interactive timeline →
Brooks Laboratories Limited
Abridge Speciality Limited
Premium access

Shareholding and investment profile for Jitendrapratap Rambahadur Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jitendrapratap Rambahadur Singh

Jitendrapratap Rambahadur Singh currently holds 2 directorships: Brooks Laboratories Limited (Whole-Time Director, since 23 Nov 2022, revenue ₹83.44 Cr (FY 2025)); Abridge Speciality Limited (Whole-Time Director, since 02 Jul 2026).

Jitendrapratap Rambahadur Singh was first appointed on 23 Nov 2022 as Whole-Time Director at Brooks Laboratories Limited. The most recent appointment on record is 02 Jul 2026 at Abridge Speciality Limited.

The current boards of Jitendrapratap Rambahadur Singh's companies include Bhushan Singh Rana (Brooks Laboratories Limited), Durga Shankar Maity (Brooks Laboratories Limited), Krutika Mohan Rane (Brooks Laboratories Limited), Lalit Mahajan (Brooks Laboratories Limited), Manav Mahajan (Brooks Laboratories Limited), Prashant Rathi (Brooks Laboratories Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available